Xconomy’s Digital Events →
GSK vice president Damien McDevitt (photo used with permission)
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
From Our Editors · Special Report
Becoming the Cell & Gene Therapy Hub
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals